APPROVAL OF THE NOVAVAX COVID 19 VACCINE
Effective October 3, 2023, the Federal Drug Administration (FDA) announced the approval of the updated 2023–2024 monovalent XBB.1.5 variant Novavax COVID-19 Vaccine, Adjuvanted.
last updated: March 13, 2024
Effective October 3, 2023, the Federal Drug Administration (FDA) announced the approval of the updated 2023–2024 monovalent XBB.1.5 variant Novavax COVID-19 Vaccine, Adjuvanted.
Talk to us about questions or concerns
Monday – Saturday | 8 a.m.– 8 p.m. (ET)
Sunday | 9 a.m.– 5 p.m. (ET)
Talk to us about any questions or concerns
Monday – Saturday | 8 a.m.– 6 p.m. (ET)
Sunday | 9 a.m.– 5 p.m. (ET)